Panelli Simona, Epis Sara, Cococcioni Lucia, Perini Matteo, Paroni Moira, Bandi Claudio, Drago Lorenzo, Zuccotti Gian Vincenzo
Department of Biomedical and Clinical Sciences "L. Sacco" and Pediatric Clinical Research Center "Romeo ed Enrica Invernizzi", University of Milano, Italy.
Department of Biosciences and Pediatric Clinical Research Center "Romeo ed Enrica Invernizzi", University of Milano, Italy.
Pharmacol Res. 2020 Sep;159:104962. doi: 10.1016/j.phrs.2020.104962. Epub 2020 May 30.
This review tackles the concept of the evolutionary mismatch, in relation with the reduction of the prevalence of the so-called "dirty old friends". These formed the variegated community of parasites and microorganisms, either prokaryotic or eukaryotic, that, over long evolutionary times, co-evolved with humans and their ancestors, inhabiting their digestive tracts, and other body districts. This community of microbial symbionts and metazoan parasites is thought to have evolved a complex network of inter-independence with the host, in particular in relation with their immune stimulating capacity, and with the consequent adaptation of the host immune response to this chronic stimulation. Strictly related to this evolutionary mismatch, the hygiene hypothesis, proposed by David Strachan in 1989, foresees that the increase in the incidence of inflammatory and autoimmune disorders during the twentieth century has been caused by the reduced exposure to parasites and microorganisms, especially in industrialized countries. Among these pathologies, inflammatory bowel diseases (IBDs) occupy a prominent role. From these premises, this review summarizes current knowledge on how variations in the composition of the gut bacterial microbiota, as well as its interactions with fungal communities, influence the overall immune balance, favouring or counteracting gut inflammation in IBDs. Additionally, the effect of worm parasites, either directly on the immune balance, or indirectly, through the modulation of bacterial and fungal microbiota, will be addressed. Finally, we will review a series of studies related to the use of molecules derived from parasitic worms and fungi, which hold the potential to be developed as postbiotics for the treatment of IBDs.
本综述探讨了进化不匹配的概念,这与所谓“老朋友病原体”患病率的降低有关。这些病原体构成了由寄生虫和微生物组成的多样化群体,包括原核生物或真核生物,在漫长的进化过程中,它们与人类及其祖先共同进化,栖息于人类的消化道及其他身体部位。人们认为,这个微生物共生体和后生动物寄生虫的群体与宿主进化出了一个复杂的相互依存网络,特别是在其免疫刺激能力方面,以及宿主免疫反应随之对这种慢性刺激的适应性方面。与这种进化不匹配密切相关的是,大卫·斯特拉坎在1989年提出的卫生假说预测,20世纪炎症性和自身免疫性疾病发病率的上升是由于接触寄生虫和微生物的减少所致,尤其是在工业化国家。在这些疾病中,炎症性肠病(IBD)占据显著地位。基于这些前提,本综述总结了当前关于肠道细菌微生物群组成的变化及其与真菌群落的相互作用如何影响整体免疫平衡,从而促进或对抗IBD肠道炎症的知识。此外,还将探讨蠕虫寄生虫直接对免疫平衡的影响,或通过调节细菌和真菌微生物群产生的间接影响。最后,我们将回顾一系列与使用源自寄生虫和真菌的分子相关的研究,这些分子有潜力被开发为用于治疗IBD的后生元。